Renaissance Technologies’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.75M | Buy |
269,077
+72,800
| +37% | +$2.37M | 0.01% | 1144 |
|
|
2025
Q1 | $7.41M | Buy |
196,277
+142,200
| +263% | +$5.37M | 0.01% | 1181 |
|
|
2024
Q4 | $4.43M | Buy |
+54,077
| New | +$4.43M | 0.01% | 1522 |
|
|
2023
Q3 | – | Sell |
-215,477
| Closed | -$10.8M | – | 3977 |
|
|
2023
Q2 | $10.8M | Sell |
215,477
-205,400
| -49% | -$10.3M | 0.02% | 984 |
|
|
2023
Q1 | $15.8M | Sell |
420,877
-101,100
| -19% | -$3.79M | 0.02% | 849 |
|
|
2022
Q4 | $25M | Buy |
521,977
+428,777
| +460% | +$20.6M | 0.03% | 607 |
|
|
2022
Q3 | $2.24M | Buy |
93,200
+20,600
| +28% | +$494K | ﹤0.01% | 1944 |
|
|
2022
Q2 | $1.58M | Buy |
72,600
+31,800
| +78% | +$692K | ﹤0.01% | 2366 |
|
|
2022
Q1 | $985K | Buy |
40,800
+27,800
| +214% | +$671K | ﹤0.01% | 2735 |
|
|
2021
Q4 | $309K | Buy |
+13,000
| New | +$309K | ﹤0.01% | 3333 |
|